Migraine, female hormones, and stroke

Cephalalgia

Volumn 19, Issue 2, 1999, Pages 75-79

  Bousser, Marie Germaine ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MIGRAINE; ORAL CONTRACEPTION; PREGNANCY; REVIEW; RISK FACTOR; SEX DIFFERENCE; STROKE;

CEREBROVASCULAR DISORDERS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIGRAINE DISORDERS; PREGNANCY;

EID: 0032954367     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1999.019002075.x     Document Type: Review

References (46)

1. Sudlow CLM, Warlow CP for the international stroke incidence collaboration. Stroke 1997;28:491-9
2. American Heart Association. Heart and stroke facts: statistical update. Dallas: American Heart Association, 1996
3. Bonita R. Epidemiology of stroke. Lancet 1992;339:342-4
4. Prencipe M, Ferretti C, Casini AR, Santini M, Giubilei F, Culasso F. Stroke, disability and dementia. Results of a population survey. Stroke, 1997;28:531-6
5. Skoog I, Nillson L, Palmeretz B, Andreasson FA, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-8
6. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997;349:1269-76
7. Murray CJL, Lopez. AD Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997;349:1498-504
8. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence and survival secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373-80
9. Truelsen T, Prescott E, Gronbaek M, Schnor P, Boysen G. Trends in stroke incidence. The Copenhagen city heart study. Stroke 1997;28:1903-7
10. Bousser MG, Massiou H. Migraine in the reproductive cycle. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press, 1993
11. Silberstein SD. The role of sex hormones in headache. Neurology 1992;42 Suppl 2:37-42
12. Bousser MG. Stroke in women. Circulation. In press
13. Hannaford PC, Croft PR, Kay CR. Oral contraception and stroke. Evidence from the Royal College of General Practitioners' oral contraception study. Stroke 1994;25:935-42
14. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid hormone Contraception: ischaemic stroke and combined oral contraceptives: Results of an international, multicentre case-control study
15. World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception: haemorrhagic stroke, overall stroke risk and combined oral contraceptives: results of an international, multicentre, case control study. Lancet 1993;348:505-10
16. Petitti DB. Sidney S, Bernstein A, Wolf S. Quesenberry C, Ziel HK. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996;35:8-15
17. Tzourio C. Iglesias S, Hubert JB, Visy JM. Alpevovitch A, Tehindrazanarivelo A, Bousser MG. Migraine and risk of ischemic stroke: a case-control study. BMJ 1993;308:289-92
18. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru E, d'A Anglejan-Chatillon J, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995;310:830-3
19. Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynecol 1995;102:153-9
20. Carolei A, Marini C. De Matteis G and the Italian National Research Council study group on stroke in the young. Lancet 1996;347:1503-6
21. Donaghy M. Chang CL, Poulter N. Migraine and stroke in young women: a case-control study. Ann Neurol 1998;44:442
22. Olesen J, Welch KMA, Carolei A. Treatment to prevent migraine-related stroke. Cerebrovasc Dis 1993;3:244-7
23. Ratinahira H, Darbois Y, Bousser MG. Migraine and pregnancy: a prospective study in 703 women after delivery. Neurology 1990;40 Suppl 1:437
24. Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy. Cephalalgia 1997;17:765-9
25. Kittner SJ, Stern BJ, Feeser BR, Hebel JR, Nagey DA, Buchholtz DW, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768-4
26. Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperîum: a study in public hospitals of Ile de France. Stroke 1995;26:930-6
27. Rascol A, Guiraud B. Manelfe C. Clanet M. Accidents vasculaires cérébraux de la grossesse et du post-partum. 2e Conférences de la Salpetrière; 1 vol. JB Baillière edn Paris, 1979
28. Bousser MG, Ross Russell R. Cerebral venous thrombosis, vol. 1. Major problems in neurology, no. 33 London: WB Saunders, 1997:175
29. Neri I, Granella F, Nappi R. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 1993;17:31-7
30. Silberstein SD, Merriam GR. Estrogens, progestins, and headache. Neurology 1991;41:786-3
31. Bush TL, Barett-Connor E. Cowan LD, Criqui MH, Wallace RB, Suchindran CM, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the lipid research clinics program follow-up study. Circulation 1987;75:1102-9
32. Wilson PWF, Garrison J, Castelli WP. Post-menopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50: the Framingham study. N Engl J Med 1985;313:1038-43
33. Pedersen AT, Lidegaard O, Kreiner S, Ottesen B. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997;350:277-83
34. Petitti DB, Sidney S, Quesenberry CP, Bernstein A. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke 1998;29:23-8
35. Mosca L, Manson JF, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women. A statement for healthcare professionals from the American Heart Association. Circulation 1997;96:2468-82
36. Grodstein F, Stampfer MJ, Manson JF, Colditz GA, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-61
37. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. JAMA 1998;280:605-13
38. Bousser MG, Baron JC, Chiras J. Ischemic strokes and migraine. Neuroradiology 1985;27:583-7
39. Welch KMA, Levine SR. Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol 1990;47:458-62
40. Wetch KMA. Relationship of stroke and migraine. Neurology 1994;44 Suppl 7:S33-6
41. D'Anglejan-Chatillon J, Ribeiro V, Mas JL, Youl BD, Bousser MG. Migraine as a risk factor for dissection of cervical arteries. Headache 1989;29:560-1
42. Olesen J, Friberg L, Skyhoj Olsen, Andersen AR, Lassen NA, Hansen PF, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993;116:187-202
43. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Mark Lathrop G, Chabriat H, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nature Genet 1993;3: 256-9
44. Chabriat II, Vahedi K, Iba-Zizen MT, Joutel AS, Nibbio A, Nagy TG, et al. Clinical spectrum of CADASIL: a study of 7 families. Lancet 1995;346:934-9
45. Joutel A, Corpechot C, Ducros A, Katayoun V, Chabriat H, Mouton P, et al. "Notch 3" mutations in CADASIL, an hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-10
46. Shinton R, Sagar G. Lifelong exercise and stroke. BMJ 1993;307:231-4